Amprius Technologies (NYSE:AMPX – Get Free Report) is expected to be issuing its Q2 2026 results before the market opens on Tuesday, August 4th. Analysts expect Amprius Technologies to post earnings of ($0.03) per share and revenue of $29.3020 million for the quarter. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 8:30 AM ET.
Amprius Technologies (NYSE:AMPX – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%. The business had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million. On average, analysts expect Amprius Technologies to post $-0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Amprius Technologies Trading Up 1.5%
Shares of Amprius Technologies stock opened at $9.61 on Friday. The company has a fifty day moving average price of $14.21 and a 200 day moving average price of $14.88. Amprius Technologies has a twelve month low of $6.07 and a twelve month high of $24.23. The stock has a market cap of $1.36 billion, a price-to-earnings ratio of -32.04 and a beta of 2.25.
Analyst Ratings Changes
Read Our Latest Research Report on AMPX
Insider Activity at Amprius Technologies
In other Amprius Technologies news, CTO Constantin Ionel Stefan sold 3,208 shares of the stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $17.19, for a total transaction of $55,145.52. Following the transaction, the chief technology officer directly owned 801,310 shares in the company, valued at $13,774,518.90. This represents a 0.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Thomas M. Stepien sold 2,000 shares of the firm’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $20.97, for a total transaction of $41,940.00. Following the transaction, the chief executive officer directly owned 625,625 shares of the company’s stock, valued at approximately $13,119,356.25. This represents a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 310,144 shares of company stock worth $5,049,997 in the last ninety days. 5.10% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Amprius Technologies
Several large investors have recently modified their holdings of AMPX. Voloridge Investment Management LLC bought a new stake in Amprius Technologies in the third quarter valued at about $19,737,000. BNP Paribas Financial Markets lifted its holdings in Amprius Technologies by 1,117.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock worth $20,450,000 after buying an additional 1,784,291 shares during the last quarter. Norges Bank acquired a new position in shares of Amprius Technologies in the 4th quarter worth approximately $10,295,000. Invesco Ltd. grew its position in shares of Amprius Technologies by 113.3% in the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock worth $25,031,000 after acquiring an additional 1,263,846 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of Amprius Technologies by 12,063.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,017,217 shares of the company’s stock valued at $4,282,000 after acquiring an additional 1,008,854 shares during the last quarter. Institutional investors own 5.04% of the company’s stock.
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Further Reading
- Five stocks we like better than Amprius Technologies
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
